Projects and Grants per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Philosophy, Virginia Commonwealth University
2000
Fingerprint
Dive into the research topics where Thomas Prisinzano is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
Liposomal azithromycin to treat cardiac inflammation
Venditto, V. (PI), Prisinzano, T. (CoI) & Feola, D. (CoPI)
National Heart Lung and Blood Institute
3/18/25 → 2/28/27
Project: Research project
-
Neurobehavioral Mechanisms Underlying Xylazine and Fentanyl Co-use and Withdrawal
Gipson-Reichardt, C. (PI), Moseley, H. (CoI), Prisinzano, T. (CoI) & Hinds, T. (CoPI)
National Institute on Drug Abuse
6/15/23 → 4/30/28
Project: Research project
-
Development of Agents for Synthetic Opioid Overdose
Prisinzano, T. (PI), Alilain, W. (CoI), Bardo, M. (CoI) & Turner, J. (CoI)
National Institute on Drug Abuse
9/1/21 → 7/31/25
Project: Research project
-
COBRE in Pharmaceutical Research and Innovation
Thorson, J. (PI), Helmy, Y. A. (CoI), Jaramillo, A. (CoI), She, Q.-B. (CoI), Adams, V. (Former CoI), Alam, M. (Former CoI), Awuah, S. (Former CoI), Bardo, M. (Former CoI), Bauer, B. (Former CoI), Burgess, D. (Former CoI), Czuba, L. (Former CoI), Daugherty, A. (Former CoI), Dwoskin, L. (Former CoI), Feola, D. (Former CoI), Garneau-Tsodikova, S. (Former CoI), Gensel, J. (Former CoI), Glazer, E. (Former CoI), Grady, M. (Former CoI), Graf, G. (Former CoI), Kapur, N. (Former CoI), Kolesar, J. (Former CoI), Korotkov, K. (Former CoI), Korotkova, N. (Former CoI), Leggas, M. (Former CoI), Mahmoud, K. A. (Former CoI), McLaurin, K. (Former CoI), Messaoudi Powers, I. (Former CoI), Nikolajczyk, B. (Former CoI), Ortinski, P. (Former CoI), Pack, D. (Former CoI), Park, J. (Former CoI), Prisinzano, T. (Former CoI), Richards, C. (Former CoI), Rohr, J. (Former CoI), Sen, P. (Former CoI), Shaffer, C. (Former CoI), Stevenson, B. (Former CoI), Sturgill, J. (Former CoI), Sviripa, V. (Former CoI), Tidgewell, K. (Former CoI), Tiruvannamalai Annam, R. (Former CoI), Turner, J. (Former CoI), Van Lanen, S. (Former CoI), Venditto, V. (Former CoI), Watt, D. (Former CoI), Webb, N. (Former CoI) & Zhan, C.-G. (Former CoI)
National Institute of General Medical Sciences
3/1/20 → 1/31/26
Project: Research project
-
Kentucky Network for Innovation & Commercialization (KYNETIC)
Dwoskin, L. (PI), McClure, I. (CoI), Prisinzano, T. (CoI), Thorson, J. (CoI) & Hall, E. (Former CoI)
National Heart Lung and Blood Institute
9/23/19 → 8/31/25
Project: Research project
-
Effects of Biased Analogues of the Kappa Opioid Receptor Agonist, U50,488, in Preclinical Models of Pain and Side Effects
van de Wetering, R., Vu, L. Y., Kornberger, L. D., Luo, D., Scouller, B., Hong, S., Paton, K., Prisinzano, T. E. & Kivell, B. M., Feb 2025, In: Molecules. 30, 3, 604.Research output: Contribution to journal › Article › peer-review
Open Access -
Transformation of a Potent C9-Substituted Phenylmorphan into MOR Partial Agonists with Improvement of Metabolic Stability: An In Vitro, In Vivo, and In Silico Study
Hernandez, D. E., Luo, D., Prisinzano, T. E., Negus, S. S., Nassehi, N., Selley, D. E., Shah, P., Kato, R., Xu, X., Talarico, C., Graziani, D., Beccari, A. R., Jacobson, A. E., Rice, K. C. & Sulima, A., Jun 4 2025, In: ACS Chemical Neuroscience. 16, 11, p. 2110-2127 18 p.Research output: Contribution to journal › Article › peer-review
-
Contingent administration of typical and biased kappa opioid agonists reduces cocaine and oxycodone choice in a drug vs. food choice procedure in male rhesus monkeys
Zamarripa, C. A., Huskinson, S. L., Townsend, E. A., Prisinzano, T. E., Blough, B. E., Rowlett, J. K. & Freeman, K. B., Feb 2024, In: Psychopharmacology. 241, 2, p. 305-314 10 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Functional Activity of Enantiomeric Oximes and Diastereomeric Amines and Cyano Substituents at C9 in 3-Hydroxy-N-phenethyl-5-phenylmorphans
Roth, H. G., Das, M., Sulima, A., Luo, D., Kaska, S., Prisinzano, T. E., Kerr, A. T., Jacobson, A. E. & Rice, K. C., Apr 23 2024, In: Molecules. 29, 9Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Nalfurafine promotes myelination in vitro and facilitates recovery from cuprizone + rapamycin-induced demyelination in mice
van de Wetering, R., Bibi, R., Biggerstaff, A., Hong, S., Pengelly, B., Prisinzano, T. E., La Flamme, A. C. & Kivell, B. M., Oct 2024, In: GLIA. 72, 10, p. 1801-1820 20 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations
Prizes
-
-
David W. Robertson Award for Excellence in Medicinal Chemistry
Prisinzano, T. (Recipient), 2012
Prize: Honorary award
-
-
-